Potential influence of concomitant medication on Ibrutinib metabolism in patient with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Pharmacodynamics
- 29 Jan 2018 New trial record